Jump Financial, LLC Silverback Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	N/A	73,810 Added 193.78%	111,900 $0
Q2 2023 Aug 07, 2023	BUY	N/A	73,810 Added 193.78%	111,900 $0
Q1 2023 Oct 21, 2024	BUY	N/A	38,090 New	38,090 $0
Q1 2023 May 03, 2023	SELL	N/A	-1,987 Reduced 4.96%	38,090 $0
Q4 2022 Feb 13, 2023	BUY	$0.0 - $6.07 $0 - $243,267	40,077 New	40,077 $0
Q1 2022 May 12, 2022	SELL	$3.51 - $6.74 $132,678 - $254,772	-37,800 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$6.03 - $11.67 $31,959 - $61,851	5,300 Added 16.31%	37,800 $252,000
Q3 2021 Nov 12, 2021	BUY	$9.98 - $35.22 $324,350 - $1.14 Million	32,500 New	32,500 $324,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.